✦ LIBER ✦

Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer

✍ Scribed by Howard H. Bailey; Steven Attia; Richard R. Love; Terri Fass; Rick Chappell; Kendra Tutsch; Linda Harris; Alcee Jumonville; Richard Hansen; Gary R. Shapiro; James A. Stewart

Publisher: Springer
Year: 2007
Tongue: English
Weight: 340 KB
Volume: 62
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0585-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of 10-EDAM in the treatme

Phase II trial of 10-EDAM in the treatment of metastatic breast cancer

✍ Garth A. Beinart; Ana M. Gonzalez-Angulo; Kristine Broglio; Debbie Frye; Ronald 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 273 KB

Phase II trial of recombinant Beta (IFN-

Phase II trial of recombinant Beta (IFN-Betaser) interferon in the treatment of metastatic breast cancer

✍ Luis Barreras; Charles L. Vogel; Grace Koch; Stephen G. Marcus 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 356 KB

Results of a phase II open-label, nonran

Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer

✍ John W. Smith; Kristi J. McIntyre; Patrick V. Acevedo; Carlos A. Encarnacion; Ka 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 230 KB

Phase II trial of an all-oral regimen of

Phase II trial of an all-oral regimen of tegafur and folinic acid in patients with previously treated metastatic breast cancer

✍ Luis A. Solé; Joan Albanell; Joaquim Bellmunt; Antonio Ribas; Oscar S. Gallego; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Phase II trial of a novel capecitabine d

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

Weekly paclitaxel, estramustine phosphat

Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma : Results of a Minnie Pearl Cancer Research Network Phase II Trial

✍ Anthony A. Meluch; F. Anthony Greco; Lisa H. Morrissey; Eric L. Raefsky; Ronald 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND The objective of the current study was to evaluate the efficacy and toxicity of weekly paclitaxel, oral etoposide, and estramustine phosphate in the treatment of patients with advanced, hormone‐refractory prostate carcinoma. ## METHODS Patients with hormone‐refractory p